Skip to main content

Table 3 DNA methylation and time to disease (TTD)

From: Gene-specific DNA methylation profiles and LINE-1 hypomethylation are associated with myocardial infarction risk

  

ZBTB12

    

LINE-1

    

TTD classa

Rangeb

Effect size

95 % CI

se

P TREND

Cochran’s Q

Effect size

95 % CI

se

P TREND

Cochran’s Q

EPICOR men

          

 TTD class 1

8.89–14.66

          

 TTD class 2

5.23–8.88

−0.0054

−0.0090;−0.0018

0.0018

0.0036

 

−0.0009

−0.0016;−0.0003

0.0003

0.0044

 

 TTD class 3

0.26–5.20

          

EPIC-NL men

          

 TTD class 1

6.97–12.31

          

 TTD class 2

3.53–6.86

−0.0093

−0.0182;−0.0005

0.0045

0.0389

 

−0.0035

−0.0070;0.00003

0.0018

0.0537

 

 TTD class 3

0.23–3.52

          

Meta-analysis

−0.0059

−0.0093;−0.0027

0.0017

0.0005

0.65c

−0.0010

−0.0017;−0.0004

0.0003

0.0016

2.03c

EPICOR women

          

 TTD class 1

8.16–14.02

          

 TTD class 2

4.40–8.06

−0.0056

−0.0106;−0.0007

0.0025

0.0250

 

−0.0008

−0.0017;0.00004

0.0004

0.0636

 

 TTD class 3

0.33–4.30

          

EPIC-NL women

          

 TTD class 1

7.35–12.30

          

 TTD class 2

4.40–7.21

−0.0047

−0.0106;0.0011

0.0030

0.1147

 

−0.0011

−0.0032;0.0010

0.0011

0.2970

 

 TTD class 3

0.04–4.38

          

Meta-analysis

−0.0053

−0.0091;−0.0015

0.0019

0.0065

0.05c

−0.0008

−0.0016;−0.0001

0.0004

0.0263

0.07c

  1. aHealthy controls (TTD class 0) were used as the reference group. Cases were divided in tertiles (TTD classes 1 to 3)
  2. bMinimum and maximum TTD (i.e., time lapse in years from enrollment to occurrence of MI) for each class
  3. cd.f. = 1, P = not significant